Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Total 13F shares
-
3,430,835
-
Share change
-
+46,342
-
Total reported value
-
$51,872,345
-
Price per share
-
$15.12
-
Number of holders
-
40
-
Value change
-
+$961,180
-
Number of buys
-
18
-
Number of sells
-
22
Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q1 2014
As of 31 Mar 2014,
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,430,835 shares.
The largest 10 holders included
Pentwater Capital Management LP, WASATCH ADVISORS INC, Polar Capital LLP, BlackRock Fund Advisors, MORGAN STANLEY, VANGUARD GROUP INC, Iguana Healthcare Management, LLC, FMR LLC, MILLENNIUM MANAGEMENT LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
40
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.